Home » PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
PDL BioPharma, Inc. (PDL) announced a significant strategic change to focus the company on the discovery and development of novel antibodies in oncology and select immunological diseases, following a months-long business and portfolio review.
PDL Biopharma
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May